Navigation Links
IVCC develops new public health insecticides
Date:11/21/2010

The Innovative Vector Control Consortium (IVCC) has received $50 million from the Bill & Melinda Gates Foundation to continue its work to develop new insecticides for the improved control of mosquitoes and other insects which transmit malaria, dengue and other neglected tropical diseases.

IVCC was established in 2005 with an initial grant of $50.7 million over five years from the foundation. Since then, an unprecedented development pipeline of new, reformulated and repurposed insecticides has been established in partnership projects with leading global chemical companies. A suite of information systems and diagnostic tools for the more effective and efficient use of insecticides has also been developed, with these products now nearing the end of their development phase and being readied for rollout in the coming year.

The new five year grant will support new and ongoing projects to develop new Active Ingredients for insecticides and to complete the existing portfolio of insecticide formulation and repurposing projects.

Chief Executive Officer Professor Janet Hemingway explained: "The need for new insecticides has never been greater. Increased funding for control programmes is saving thousands of lives but malaria is still killing one child in Africa every 45 seconds. Resistance to insecticides is increasing at an alarming rate and we must find new alternatives even if we are to stay still in our battle against this and other vector borne diseases.

"This award allows us continue the pioneering work we're doing in partnership with the chemical industry to find and develop totally new classes of insecticide to help put an end to this needless loss of life. Our strategic aim is to provide three new Active Ingredients for use in public health insecticides by 2020."


'/>"/>

Contact: Alan Hughes
a.p.hughes@liv.ac.uk
44-151-705-3308
Liverpool School of Tropical Medicine
Source:Eurekalert

Page: 1

Related biology news :

1. NC State develops more precise genetic off switches
2. Yale develops new animal model for hemophilia A
3. Research develops simple recipe for fungus-free horseradish
4. CCNY-led team develops non-toxic oil recovery agent
5. Harvards Wyss Institute develops technology to produce sugar from photosynthetic bacteria
6. ISU researcher develops green, bio-based process for producing fuel additive
7. Military develops multi-purpose green decontaminants for terrorist attack sites
8. CSIRO develops highest-yielding salt-tolerant wheat
9. Tiny gold probes give scientists a sense of how disease develops
10. University of the Basque Country develops system for identifying illnesses in Paraguay
11. New strategy develops 2 prototype drugs against cancer, retinal diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology: